Mutations in the COL4A4 gene in thin basement membrane disease

被引:62
作者
Buzza, M
Dagher, H
Wang, YY
Wilson, D
Babon, JJ
Cotton, RG
Savige, J [1 ]
机构
[1] Univ Melbourne, Dept Med, Austin & Repatriat Med Ctr, Heidelberg, Vic 3084, Australia
[2] St Vincents Hosp, Genom Disorders Res Ctr, Fitzroy, Vic 3065, Australia
基金
英国医学研究理事会;
关键词
gene mutations; hematuria; heredity; S969X mutation; R1377X mutation; dysmorphic red blood cells; benign familial hematuria; familial glomerulonephritis;
D O I
10.1046/j.1523-1755.2003.00780.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Patients with thin basement membrane disease (TBMD) are often from families where hematuria segregates with the COL4A3 and COL4A4 genes. These genes also are affected in autosomal recessive Alport syndrome. The aim of this study was to demonstrate COL4A4 mutations in TBMD. Methods. Forty-eight unrelated individuals with TBMD who had no family members with autosomal recessive Alport syndrome were examined for COL4A4 mutations. The diagnosis of TBMD had been confirmed by renal biopsy (43/48, 90%) or by a family history of hematuria but without a renal biopsy (5/48, 10%). The 47 coding exons of COL4A4 were screened for mutations with the methods of enzyme mismatch cleavage or single stranded conformational polymorphism (SSCP) analysis, and exons that demonstrated electrophoretic abnormalities were sequenced. Results. Nine variants that altered the coding sequences were identified. These were nonsense and frameshift mutations that resulted in stop codons (N = 3), and glycine (N = 3) and non-glycine missense variants (N = 3). Four intronic variants and three neutral polymorphisms were also detected. In total, four variants were considered 'pathogenic' principally because they resulted in stop codons or were not present in non-hematuric normal subjects. Three variants were considered 'possibly pathogenic' but two of these were each present in one of 46 non-hematuric normal subjects. Conclusions. Pathogenic COL4A4 mutations were demonstrated in three of the nine (33%) families in whom hematuria segregated with the COL4A3/COL4A4 locus. Two stop codons (R1377X and 2788/91delG) and a glycine substitution (G960R) resulted in hematuria in all 16 members who were tested from these three families. The S969X mutation described here in TBMD for the first time, as well as the R1377X mutation, also occur in autosomal recessive Alport syndrome.
引用
收藏
页码:447 / 453
页数:7
相关论文
共 41 条
[1]  
Badenas C, 2002, J AM SOC NEPHROL, V13, P1248, DOI 10.1681/ASN.V1351248
[2]   2 CA-DINUCLEOTIDE POLYMORPHISMS AT THE COL4A5 (ALPORT SYNDROME) GENE IN XQ22 [J].
BARKER, DF ;
CLEVERLY, J ;
FAIN, PR .
NUCLEIC ACIDS RESEARCH, 1992, 20 (04) :929-929
[3]   IDENTIFICATION OF MUTATIONS IN THE COL4A5 COLLAGEN GENE IN ALPORT SYNDROME [J].
BARKER, DF ;
HOSTIKKA, SL ;
ZHOU, J ;
CHOW, LT ;
OLIPHANT, AR ;
GERKEN, SC ;
GREGORY, MC ;
SKOLNICK, MH ;
ATKIN, CL ;
TRYGGVASON, K .
SCIENCE, 1990, 248 (4960) :1224-1227
[4]   ESTABLISHING THE DIAGNOSIS OF BENIGN FAMILIAL HEMATURIA - THE IMPORTANCE OF EXAMINING THE URINE SEDIMENT OF FAMILY MEMBERS [J].
BLUMENTHAL, SS ;
FRITSCHE, C ;
LEMANN, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 259 (15) :2263-2266
[5]   Determination of the genomic structure of the COL4A4 gene and of novel mutations causing autosomal recessive Alport syndrome [J].
Boye, E ;
Mollet, G ;
Forestier, L ;
Cohen-Solal, L ;
Heidet, H ;
Cochat, P ;
Grünfeld, JP ;
Palcoux, JB ;
Gubler, MC ;
Antignac, C .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 63 (05) :1329-1340
[6]   COL4A4 mutation in thin basement membrane disease previously described in Alport syndrome [J].
Buzza, M ;
Wang, YY ;
Dagher, H ;
Babon, JJ ;
Cotton, RG ;
Powell, H ;
Dowling, J ;
Savige, J .
KIDNEY INTERNATIONAL, 2001, 60 (02) :480-483
[7]   Segregation of hematuria in thin basement membrane disease with haplotypes at the loci for Alport syndrome [J].
Buzza, M ;
Wilson, D ;
Savige, J .
KIDNEY INTERNATIONAL, 2001, 59 (05) :1670-1676
[8]   Identification of a new mutation in the α4(IV) collagen gene in a family with autosomal dominant Alport syndrome and hypercholesterolaemia [J].
Ciccarese, M ;
Casu, D ;
Wong, FK ;
Faedda, R ;
Arvidsson, S ;
Tonolo, G ;
Luthman, H ;
Satta, A .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (10) :2008-2012
[9]   Collagen COL4A3 knockout: A mouse model for autosomal Alport syndrome [J].
Cosgrove, D ;
Meehan, DT ;
Grunkemeyer, JA ;
Kornak, JM ;
Sayers, R ;
Hunter, WJ ;
Samuelson, GC .
GENES & DEVELOPMENT, 1996, 10 (23) :2981-2992
[10]   A comparison of the clinical, histopathologic, and ultrastructural phenotypes in carriers of X-linked and autosomal recessive Alport's syndrome [J].
Dagher, H ;
Buzza, M ;
Colville, D ;
Jones, C ;
Powell, H ;
Fassett, R ;
Wilson, D ;
Agar, J ;
Savige, J .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (06) :1217-1228